CHA2DS2-VA and non-CHA2DS2-VA components as predictors of mortality after cavotricuspid isthmus ablation: a clinical tool for long-term risk stratification.

Front Cardiovasc Med · 2026 · PMC13429838 · PMID 42548898

Europe PMC DOI

hedged sentences

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

highly significantp < 0.001actually significant

Notably, this cut-off also provided the strongest separation of Kaplan–Meier survival curves, with a highly significant log-rank test ( p < 0.001).

also in 132,142 other papers

an overall trendno p-value reported

These differences reflect an overall trend across strata. post-hoc pairwise log-rank comparisons using Holm-Bonferroni correction identified significant differences primarily between lower and higher CHA 2 DS 2 -VA score categories.

also in 4,871 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

CHA&lt;sub&gt;2&lt;/sub&gt;DS&lt;sub&gt;2&lt;/sub&gt;-VA and non-CHA&lt;sub&gt;2&lt;/sub&gt;DS&lt;sub&gt;2&lt;/sub&gt;-VA components as predictors of mortality after cavotricuspid isthmus ablation: a clinical tool for long-term risk stratification.

The sentences

CHA<sub>2</sub>DS<sub>2</sub>-VA and non-CHA<sub>2</sub>DS<sub>2</sub>-VA components as predictors of mortality after cavotricuspid isthmus ablation: a clinical tool for long-term risk stratification.